Researchers focused on men with medium- and high-risk localized
prostate tumors likely to benefit from aggressive treatment like
surgery or radiation, rather than the conservative approaches of
watchful waiting or hormone therapy often used for men with low-risk
While 83% of white men received aggressive treatment, just 74% of
black men did, the study found.
“Given the evidence suggesting a benefit for treatment in men
diagnosed with intermediate- and high-risk prostate cancer, our
findings may explain, to some degree, the differences in survival
odds between black and white men diagnosed with prostate cancer,"
said lead study author Dr. Quoc-Dien Trinh, co-director of the
Dana-Farber/Brigham and Women's Prostate Cancer Center in Boston.
Black men are more likely to develop prostate cancer and to die from
it than white men, the researchers note in European Urology, online
August 2. Black patients are also more likely to be diagnosed when
tumors are more advanced and more difficult to treat.
For the current study, researchers examined national cancer registry
data on 223,873 white men and 59,262 black men aged 40 or older
diagnosed with prostate tumors in the U.S. between 2004 and 2013.
Half of the white men in the study were at least 65 years old, while
half of the black men were at least 63.
Black men were more likely to be low-income and uninsured or covered
by Medicaid, the U.S. health program for the poor.
During the study period, the proportion of white men receiving
aggressive treatment rose from 81% to 83%, while for black men it
increased from 73% to 75%.
Overall, 39% of the 356 facilities in the study were significantly
more likely to give aggressive therapy to white men than to black
men with similar tumors. Only 1% of facilities were more likely to
give aggressive treatment to black men.
Geography also played a role. For example, in the southeastern U.S.,
white men were 69% more likely to receive aggressive treatment than
black men, the study found.
“From a system-level perspective, we need to do a better job to
(standardize) prostate cancer counseling and recommendations,” Trinh
said by email. “There is no reason why there would be such a
variation in how black men are treated from one institution to
[to top of second column]
One limitation of the study is that researchers lacked data on
patient preferences that may have driven treatment decisions.
Researchers also lacked data on patients treated at smaller
facilities and places that treated fewer than 50 men a year for
It’s also hard to say how many patients may have opted against
aggressive treatment because they didn’t trust their physician or
worried about side effects like urinary incontinence or erectile
dysfunction, said Dr. Simpa Salami, a urologist at the University of
Michigan in Ann Arbor who wasn’t involved in the study.
“We do not know if black men were offered definitive therapy at the
same rate as white men but chose other options instead, or if black
men were simply not offered the same treatment options as white
men,” Salami said by email.
Differences in income and insurance may also help explain the
disparities in how men were treated, said Dr. Brian Chapin of the
University of Texas MD Anderson Cancer Center in Houston.
“I would expect that if a comparison was made between whites and
blacks within the same income bracket and equivalent insurances, the
findings may not have been as significantly different,” Chapin, who
wasn’t involved in the study, said by email.
Even so, the findings suggest that men should speak to more than one
doctor before deciding how to proceed, Chapin said.
“I would encourage any newly diagnosed prostate cancer patient to
obtain a second opinion regarding their cancer care, and meet with
both a radiation oncologist and a urologist to be presented with all
available options and make sure they are fully informed before
making a treatment decision,” Chapin advised.
Eur Urol 2017.
[© 2017 Thomson Reuters. All rights
Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.